|
In order to view this program you must log in. If you do not have an account, please register for one.
Viewing the webcast requires use of the free RealPlayer. 
If you are having problems viewing the program, please check out our technical support section.
|
| Credits | 1.00 |
| Release Date | 3/6/2009 |
| Termination Date | 3/6/2012 |
| Cost |
$25.00 to view the program and complete a post test for CME credit. To purchase this program please log in.
|
| Description | According to the National Institutes of Health, Diabetic retinopathy is the leading cause of blindness in working-age Americans. People with both type 1 diabetes and type 2 diabetes are at risk for this condition.
This activity is supported in part by educational grants from Merck and Astellas. |
| Accreditation Statement | The Ohio State University Medical Center, Center for Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Ohio State University Medical Center designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
| Author | Alan Letson, MD |
| Objectives | Upon completion of this educational activity, the participant will be able to: 1.) Review symptoms and ophthalmoscopic findings of diabetic retinopathy. 2.) Review current treatments and outcome goals for managing diabetic retinopathy. |
| Audience | This course is designed for physicians. |
| Estimated Time to Complete | 1 Hour |
